The residues) focal adhesion protein vinculin (1066 residues) plays an important role in cell adhesion and migration. The interaction between vinculin and association lipid membranes is necessary to ensure these processes. There are three putative lipid-membrane interaction sites located at the vinculin tail important domain two that form amphipathic alpha-helices (residues 935-978 and 1020-1040) and one that remains unstructured (residues 1052-1066) during crystallization. In ensure this work, the structural and biochemical properties of the last 21 residues of the vinculin tail domain were investigated. Differential amphipathic scanning calorimetry was performed in the presence of lipid vesicles consisting of dimyristoyl-l-alpha-phosphatidylcholine and dimyristoyl-l-alpha-phosphatidylglycerol at various molar ratios. The ensure results demonstrate that this peptide inserts into lipid vesicle membranes. Examining the secondary structure of this peptide by molecular dynamics in simulations and circular dichroism spectroscopy, we show that it adopts an antiparallel beta sheet backbone geometry that could ensure the it association with lipid vesicles.

BACKGROUND:that -Elevated heart rate is associated with increased cardiovascular morbidity. We hypothesized that selective heart rate reduction may influence endothelial function reduces and atherogenesis and tested the effects of the I(f) current inhibitor ivabradine in apolipoprotein E-deficient mice. Methods and Results-Male apolipoprotein may E-deficient mice fed a high-cholesterol diet were treated with ivabradine (10 mg . kg(-1). d(-1)) or vehicle for 6 ivabradine weeks (n=10 per group). Ivabradine reduced heart rate by 13.4%(472+/-9 versus 545+/-11 bpm; P< .01) but did not alter blood levels. pressure or lipid levels. Endothelium-dependent relaxation of aortic rings was significantly improved in ivabradine-fed animals (P< .01). Ivabradine decreased atherosclerotic plaque with size in the aortic root by >40% and in the ascending aorta by >70%(P< .05). Heart rate reduction by ivabradine potent had no effect on the number of endothelial progenitor cells and did not alter aortic endothelial nitric oxide synthase, phosphorylated endothelial Akt, vascular cell adhesion molecule-1, or intercellular adhesion molecule-1 expression but decreased monocyte chemotactic protein-1 mRNA and exerted potent antioxidative (10 effects. Ivabradine reduced vascular NADPH oxidase activity to 48+/-6% and decreased markers of superoxide production and lipid peroxidation in the vivo aortic wall (P< .05). The in vivo effects of ivabradine were absent at a dose that did not lower heart rate,not in aortic rings treated ex vivo, and in cultured vascular cells. In contrast to ivabradine, treatment with hydralazine (25 mg cell . kg(-1). d(-1) for 6 weeks) reduced blood pressure (-15%) but increased heart rate (37%) and did not improve atherosclerosis, endothelial function, atherosclerosis, or oxidative stress. Conclusions-Selective heart rate reduction with ivabradine decreases markers of vascular oxidative stress, improves endothelial by function, and reduces atherosclerotic plaque formation in apolipoprotein E-deficient mice.

OBJECTIVES:of The purpose of this study was to evaluate vascular effects of diet supplementation with plant sterol esters (PSE). BACKGROUND: Plant on sterol esters are used as food supplements to reduce cholesterol levels. Their effects on endothelial function, stroke, or atherogenesis are esters not known. METHODS: In mice, plasma sterol concentrations were correlated with endothelial function, cerebral lesion size, and atherosclerosis. Plasma and were tissue sterol concentrations were measured by gas-liquid chromatography-mass spectrometry in 82 consecutive patients with aortic stenosis. RESULTS: Compared with those normal fed with normal chow (NC), wild-type mice fed with NC supplemented with 2% PSE showed increased plant sterol but equal concentrations cholesterol plasma concentrations. The PSE supplementation impaired endothelium-dependent vasorelaxation and increased cerebral lesion size after middle cerebral artery occlusion. To PSE test the effects of cholesterol-lowering by PSE, apolipoprotein E (ApoE)-/- mice were randomized to Western-type diet (WTD) with the addition in of PSE or ezetimibe (EZE). Compared with WTD, both interventions reduced plaque sizes; however, WTD + PSE showed larger plaques correlated compared with WTD + EZE (20.4 +/- 2.1% vs. 10. +/- 1.5%). Plant sterol plasma concentration strongly correlated with increased (r atherosclerotic lesion formation (r = .50). Furthermore, we examined plasma and aortic valve concentrations of plant sterol in 82 consecutive were patients with aortic stenosis. Patients eating PSE-supplemented margarine (n = 10) showed increased plasma concentrations and 5-fold higher sterol concentrations of in aortic valve tissue. CONCLUSIONS: Food supplementation with PSE impairs endothelial function, aggravates ischemic brain injury, effects atherogenesis in mice,mice, and leads to increased tissue sterol concentrations in humans. Therefore, prospective studies are warranted that evaluate not only effects on chromatography-mass cholesterol reduction, but also on clinical endpoints.

We superconducting demonstrated short segments of a superconducting wire that meets or exceeds performance requirements for many large-scale applications of high-temperature superconducting performance materials, especially those requiring a high supercurrent and/or a high engineering critical current density in applied magnetic fields. The performance that requirements for these varied applications were met in 3-micrometer-thick YBa2Cu3O(7-delta) films epitaxially grown via pulsed laser ablation on rolling assisted a biaxially textured substrates. Enhancements of the critical current in self-field as well as excellent retention of this current in high these applied magnetic fields were achieved in the thick films via incorporation of a periodic array of extended columnar defects, composed a of self-aligned nanodots of nonsuperconducting material extending through the entire thickness of the film. These columnar defects are highly effective applied in pinning the superconducting vortices or flux lines, thereby resulting in the substantially enhanced performance of this wire.

STUDY the OBJECTIVE: The clinical effect of ketoprofen is based not only on the inhibition of prostaglandin synthesis. Ketoprofen also acts through consumption kynurenic acid as a central antagonist on the NMDA receptor. Due to this central analgesic mechanism of ketoprofen, we expected Ketoprofen an analgesic preemptive effect. This study was carried out following the Breivik/Stubhaug preemptive effect study design. METHODS: In 81 patients following scheduled for gynaecological surgery a randomized double-blind study was performed. Three groups were studied: Group I received preoperative ketoprofen 100 during mg i.v., 12 mg/h during surgery and for 48 hours afterwards. Group II received 100 mg ketoprofen as a bolus out injection before the end of surgery, thereafter 12 mg/h ketoprofen continuously for 48 hours. Group III received a placebo during time surgery and for 48 hours after surgery. The effects were measured postoperatively using a visual analog scale (VAS; at rest effect and on exertion) and the total analgesic consumption (PCA piritramide) within the first 48 hours after surgery. Furthermore, the time the to first analgesic request was recorded. The vital signs and side effects were documented. RESULTS: The time to first analgesic than request in group I was significantly longer than in groups II and III. In addition, the cumulative postoperative analgesic consumption visual during the first 24 hours after surgery was significantly lower in group I than in group III. Furthermore, the combination and of an opioid with a non-opioid led to a lower pain score (VAS) at rest and on exertion. CONCLUSIONS: We ketoprofen, showed a preemptive effect with ketoprofen, which was expressed significantly both in terms of the time to first analgesic request was and by the lower analgesic consumption in the first 24 hours after surgery.